Targeting the $5 BILLION Soft Tissue Repair Market

Chitogenx is in the regulatory lead for regenerative products + signs MOU with major Medical Institute

Free
Message: SmallCap 60: Chitogenx (CHGX: CSE) (CHNXF: OTCQB) platform is designed to deliver biologics such as #PRP to augment and guide regeneration of new...

SmallCap 60: Chitogenx (CHGX: CSE) (CHNXF: OTCQB) platform is designed to deliver biologics such as #PRP to augment and guide regeneration of new...

posted on Sep 22, 2022 03:03PM

Share
New Message
Please login to post a reply